Spontaneous Platelet Aggregation in Cerebrovascular Disease II

Summary

A group of 186 patients with Transient Ischaemic Attacks (TIA) or cerebral Infarction (Cl) was found to demonstrate in vitro Spontaneous Platelet Aggregation (SPA) in 39% of those studied. Of the 176 normal subjects studied the incidence of in vitro SPA was found to be 5%. Further investigation of the phenomenon of SPA revealed that:

1. it is associated with ADP-hyperaggregability, i. e. the threshold concentration to induce second wave aggregation is decreased;

2. it is dependant on the increase in pH which occurs in platelet-rich plasma stirring in an aggregometer while concurrent ADP-hyperaggregability is independant of this change in pH;

3. it is associated with malondialdehyde production and the release of endogenous 5- hydroxytryptamine; and that

4. in addition K_m and V_max values for [¹⁴C]-5HT incorporation are normal; and that

5. no gross abnormalities of the platelet membrane glycoproteins were apparent although occasionally glycoprotein III was found to be increased.

This study demonstrates abnormal platelet behaviour in patients with TIA and Cl where the enzyme system involved in thromboxane production is sufficiently stimulated, by stirring alone, to induce aggregation of platelets and the release reaction.

Acetylsalicylic acid abolishes SPA and prolongs the bleeding time with similar characteristics as has been described for normal individuals. Plasma (3-thromboglobulin levels are significantly increased in the patients studied. However, no correlation was established with the incidence of in vitro SPA.

• References

• 1 Aster RH, Jandl JH. 1964; Platelet sequestration in man I. Methods. Journal of Clinical Investigation 43: 843
• 2 Breddin K, Grun H, Krzywanek HJ, Schremmer WP. 1976; On the measurements of Spontaneous Platelet Aggregation. The Platelet Aggregation Test III. Methods and first clinical results. Thrombosis and Haemostasis 35: 669
• 3 Cate JW, Ten Vos J, Oosterhuis H, Prenger D, Jenkins CS P. 1978; Spontaneous Platelet Aggregation in cerebrovascular disease. Thrombosis and Haemostasis 39: 223
• 4 Clemetson KJ, Pfueller SL, Lüscher EF, Jenkins CS P. 1977; Isolation of the membrane glycoproteins of human bloodplatelets by lectin affinity chromatography. Biochimica et Biophysica Acta 464: 493
• 5 Coller BS, Franza BR, Gralmick HR. 1976; The pH dependence of quantitative ristocetin-induced platelet aggregation: Theoretical and practical implications, a new device for maintenance of platelet-rich plasma pH. Blood 47: 841
• 6 Colman RW. 1977; Platelet function in hyperbetalipoproteinemia. Thrombosis and Haemostasis, 38: 55 Abstr
• 7 George JN, Potterf RD, Lewis PC, Sears DA. 1976; Studies on platelet plasma membranes. I. Characterisation of surface proteins of human platelets, labeled with diazotized [¹²⁵I]- diiodosulfanilic acid. Journal of Laboratory and Clinical Medicine 88: 232
• 8 George JN, Lewis PC, Sears DA. 1976; Studies on platelet plasma membranes. II. Characterisation of surface proteins by rabbit platelets in vitro during circulation in vivo using [¹²⁵I]- diiodosulfanilic acid as a label. Journal of Laboratory and Clinical Medicine, 88: 247
• 9 Gahmberg CG, Hakomori SI. 1973; External labeling of cell surface galactose and galactosamine in glycolipid and glycoprotein of human erythrocytes. Journal of Biological Chemistry 248: 4311
• 10 Halushka PV, Lurie D, Colwell JA. 1977; Increased synthesis of prostaglandin-E-like material by platelets from patients with diabetes mellitus. New England Journal of Medicine 297: 1306
• 11 Jenkins CS P, Phillips DR, Clemetson KJ, Meyer D, Larrieu MJ, Lüscher EF. 1976; Platelet membrane glycoproteins implicated in ristocetin-induced aggregation. Studies of the proteins on platelets from patients with Bernard-Soulier syndrome and von Willebrand disease. Journal of Clinical Investigation 57: 112
• 12 Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. 1951; Protein measurements with the Folin phenol reagent. Journal of Biological Chemistry 193: 265
• 13 Ludlam CA, Cash JD. 1976; Studies on the liberation of p-thromboglobulin from human platelets in vitro. British Journal of Haematology 33: 239
• 14 O’Malley BC, Ward JD, Timperley WR, Porter NR, Preston FE. 1975; Platelet abnormalities in diabetic peripheral neuropathy. Lancet 2: 1274
• 15 Massini P, Lüscher EF. 1974; Some effects of ionophores for divalent cations on blood platelets. Comparison with the effects of thrombin. Biochimica et Biophysica Acta 372: 109
• 16 MIELKE JR CH, Kaneshiro MM, Maher IA, Weiner JM, Rapaport SI. 1969; The standard normal Ivy bleedingtime and its prolongation by aspirin. Blood 34: 204
• 17 Murphy EA, Frances ME. 1971; The estimation of blood platelet survival. II. The multiple hit theory. Thrombosis et Diathesis Haemorrhagica 25: 53
• 18 Pepper DS, Ludlam CA. 1977; β-thromboglobulin (B-tg). A new approach to the diagnosis of thrombosis. In: Mills DC B, Pareti FI. Eds Platelets and thrombosis p. 45
• 19 Phillips DR. 1972; Effect of trypsin on the exposed polypeptides and glycoproteins in the human platelet membrane. Biochemistry 11: 4582
• 20 Rodman NF, Penick GD. 1972; The effect of pH on platelet aggregation responses. Blood 40: 953
• 21 Samuelson B, Hamberg M, Malmsten C, Svensson J. 1976; The role of prostaglandin endoperoxides and thromboxanes in platelet aggregation. Advances in Prostaglandin and Thromboxane Research 2: 737
• 22 Smith JB, Ingerman CM, Silver MJ. 1976; Malondialdehyde formation as an indicator of prostaglandin production by human platelets. Journal of Laboratory and Clinical Medicine 88: 167
• 23 Vreeken J, Van Aken WG. 1971; Spontaneous Aggregation of blood platelets as a cause of idiopathic thrombosis and recurrent painful toes and fingers. Lancet 2: 1394
• 24 Wu KK, Hoak JC. 1976; Spontaneous Platelet Aggregation in Arterial Insufficiency: Mechanisms and Implications. Thrombosis and Haemostasis 35: 702